AI is no longer a future concept in lifesciences, it’s actively being deployed across business processes from regulatory submissions to manufacturing monitoring to quality operations.
But while adoption is accelerating, governance and validation approaches are struggling to keep up. Most organizations we work with today are under-validating AI.
Speakers:
🎤 Margaret Hindley: Sr. Director, Computer Software Assurance, Taiho Oncology, Inc.
🎤 Stephen Cook: Sr. Director – Governance & Operational Excellence, GSK
🎤 David DeLuca: Director, Strategic Consulting, Compliance Group
🎤 Sarada Ramamoorthy: Head- Strategic Consultant, Compliance Group
Meeting date: May 5, 2026, 11 AM to 12 PM ET
